Patient safety challenges in treprostinil therapy

Treprostinil (Remodulin) is a new therapy for pulmonary hypertension. A multidisciplinary plan for safely managing the drug is described, and includes a flow chart to guide practice through high-risk issues.

Saved in:

Bibliographic Details
Published in:	Medsurg nursing Vol. 17; no. 2; p. 101
Main Authors:	Roncesvalles, Agnes, Lee, Fu Wen, Camamo, James, Priestley, Gail
Format:	Journal Article
Language:	English
Published:	United States 01-04-2008
Subjects:	Academic Medical Centers Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Drug Monitoring - methods Drug Monitoring - nursing Epoprostenol - adverse effects Epoprostenol - analogs & derivatives Epoprostenol - therapeutic use Equipment Design Equipment Failure Humans Hypertension, Pulmonary - classification Hypertension, Pulmonary - diagnosis Hypertension, Pulmonary - drug therapy Infusion Pumps - supply & distribution Infusions, Intravenous Nursing Assessment Nursing Records Patient Care Planning - organization & administration Patient Care Team - organization & administration Patient Education as Topic Safety Management - organization & administration Severity of Illness Index Southwestern United States Total Quality Management - organization & administration
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Treprostinil (Remodulin) is a new therapy for pulmonary hypertension. A multidisciplinary plan for safely managing the drug is described, and includes a flow chart to guide practice through high-risk issues.
ISSN:	1092-0811